Stay updated on XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.

Latest updates to the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedA banner announces an NIH website transition and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.8%

- Check21 days agoChange DetectedThe site revision shown in the footer changed from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.1%

- Check28 days agoChange DetectedThe website footer now identifies the site software as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study history includes a new revision tag (v3.7.0) and a small UI text change for the contact information label, reflecting a minor update to the version history and its presentation.SummaryDifference0.2%

- Check70 days agoChange DetectedThe study record history now includes a new revision entry v3.6.6, indicating an update to the page revision. This replaces the prior v3.6.5 entry and reflects an administrative update to the page.SummaryDifference0.1%

Stay in the know with updates to XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.